{"id":"NCT00579982","sponsor":"GlaxoSmithKline","briefTitle":"An Open-Label Trial Measuring Satisfaction And Convenience Of Two Formulations Of Lamotrigine In Subjects With A Mood Disorder","officialTitle":"An Open-Label Trial Measuring Satisfaction and Convenience of Two Formulations of Lamotrigine in Subjects With a Mood Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-01","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2007-12-24","resultsPosted":"2009-08-03","lastUpdate":"2016-12-16"},"enrollment":97,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Mood Disorders"],"interventions":[{"type":"DRUG","name":"Lamotrigine","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"}],"summary":"To determine the convenience and satisfaction of new orally disintegrating tablet formulation (ODT) of lamictal in subjects with a mood disorder. This was a multicenter, open-label study in participants with a mood disorder, who reported difficulty or discomfort in swallowing the currently marketed IR compressed tablet formulation of lamotrigine and who had a person (such as a spouse, partner, companion, aid, nurse, caregiver, etc) willing to complete a Companion/Caregiver Question. Subjects were switched from the currently marketed lamotrigine IR formulation to a matching dose of lamotrigine IR orally disintegrating tablet (ODT) for 3 weeks to determine convenience and satisfaction.","primaryOutcome":{"measure":"Mean Change From Baseline in the Convenience Subscale Score (CSS) Derived From the Treatment Satisfaction Questionnaire for Medication (TSQM v 1.4) Using Items 9 (Ease of Use), 10 (Ease of Planning to Use), and 11 (Convenience) at Week 3.","timeFrame":"Baseline, End of Study (Week 3) or Early Withdrawal","effectByArm":[{"arm":"Lamotrigine","deltaMin":23.3,"sd":22.5}],"pValues":[{"comp":"OG000","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":14},"locations":{"siteCount":18,"countries":["United States"]},"refs":{"pmids":["23687443"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":97},"commonTop":["Headache","Anxiety","Depression","Hypomania","Nausea"]}}